Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide)

Similar documents
Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)

THYROID IMAGING STUDY (Tc-99m as Sodium Pertechnetate)

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin)

Austin Radiological Association Nuclear Medicine Procedure GASTRIC EMPTYING STUDY (Tc-99m-Sulfur Colloid in Egg)

2. RADIOPHARMACEUTICALS UTILIZED

Austin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered])

Austin Radiological Association Nuclear Medicine Procedure PROSTATE CANCER STUDY (In-111-Capromab Pendetide [ProstaScint ])

I-123 Thyroid Scintigraphy

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

DRAXIMAGE SODIUM IODIDE I 131 CAPSULES, USP DIAGNOSTIC. For Oral Use DESCRIPTION

1. OVERVIEW AND INDICATIONS

Thyroid Uptake and Scan

Chapter 22 THYROID UPTAKE TEST. R.D. Ganatra

DRAXIMAGE SODIUM IODIDE I 131 SOLUTION USP DIAGNOSTIC. For Oral Use DESCRIPTION

Palliative treatment of bone metastases with samarium-153

Austin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir)

Sodium Iodide I 131 Solution. Click Here to Continue. Click Here to Return to Table of Contents

Austin Radiological Association TUMOR GLUCOSE METABOLISM STUDY (F-18-Fluorodeoxyglucose)

Radiopharmaceutical: Cr-51 RBCs, µci Useful in evaluating patients with anemia of unknown etiology when a hemolytic process is suspected

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

AN INTRODUCTION TO NUCLEAR MEDICINE

Click Here to Continue. Click Here to Return to Table of Contents

REGISTRATION INFORMATION

Iodine 131 thyroid Therapy. Sara G. Johnson, MBA, CNMT, NCT President SNMMI-TS VA Healthcare System San Diego

Medical Physics 4 I3 Radiation in Medicine

SODIUM IODIDE I 131 CAPSULES THERAPEUTIC 01/ Page 1 of 11

Facilitating Lu 177 Personalized Dosimetry for Neuroendocrine Tumours CANM 2017

GALLIUM CITRATE Ga 67 INJECTION

Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist

FULL PRESCRIBING INFORMATION

Applications of radioactivity in medicine

General Nuclear Medicine

Internal Dosimetry of Human Brain for 99m tc and 131 I Using Nuclear Imaging in Bangladesh

EANM Procedure Guideline For Therapy with Iodine-131

Warning: The intravenous administration of sodium perchlorate mentioned in this recommendation is a non-registered application.

Physics of MBI (~10 slides)

Whole-body biodistribution and radiation dosimetry estimates for the β-amyloid radioligand [ 11 C]MeS-IMPY in non-human primates

Detection of abscesses and infection in soft tissues, particularly in patients without localizing findings.

Time of maximum uptake of Technetium-99m pertechnetate (TcO4) in the thyroid gland and its correlation with thyroid functional status

Basics of nuclear medicine

Liver Scan Biliary with Ejection Fraction Measurement

PHYSICAL CHARACTERISTICS

A Snapshot on Nuclear Cardiac Imaging

Determination of Beta Radiation Dose to the Thyroid Gland from the Ingestion of 131 I by Patients

Table 1 Principal Radiation Emission Data * Disintegration. Gamma Ka 1 X-ray

The Effect of Administered Activity on Patient Radiation dose and Image Quality in SPECT at Korle-Bu Teaching Hospital

Is a field of radiology that uses unsealed radiation for diagnostic or therapeutic reasons Is a method of physiologic imaging, very different than

Click Here to Continue. Click Here to Return to Table of Contents

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Unit Eleven - The Endocrine System

R: March, E D T P A. Kit for the Preparation of Technetium Tc 99m Pentetate Injection. DIAGNOSTIC - For Intravenous Use

Monitoring of iodine-125 and iodine-131 in thyroid of individuals in nuclear medicine centers of North West provinces of Iran

45 Hr PET Registry Review Course

GASTRIC EMPTYING STUDY (SOLID)

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

Page 1 of CONTRAINDICATIONS None (4)

GLUCEPTATE. Technetium Tc 99m Gluceptate Kit DIAGNOSTIC DESCRIPTION

Tc-99m Sestamibi/Tetrofosmin Stress-Rest Myocardial Perfusion Scintigraphy

Brain Perfusion SPECT

PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5)

Radiation Safety for New Medical Physics Graduate Students

Radiation Detection and Measurement

Quantitative Theranostics in Nuclear Medicine

Tracking Doses in the Pediatric Population

INTRACAVITARY THERAPY FOR FLUID OR NEOPLASM (P-32 as Chromic Phosphate Colloid)

Radiation Dosimetry for CT Protocols

Haifeng Hou, 1,2,3,4 Shu Hu, 5 Rong Fan, 5 Wen Sun, 5 Xiaofei Zhang, 6 and Mei Tian 1,2,3,4. 1. Introduction

Thyroid and Antithyroid Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine April 2014

Captus 3000 Thyroid Uptake And Well System The Ultimate... User Friendly... Intuitive

Decoding Your Thyroid Tests and Results

Amira K. Brown, Ph.D. Molecular Imaging Branch, NIMH Bldg. 1 Rm. B3-10

Procedure: I-131 Tx for Hyperthyroidism

Thyroid and Antithyroid Drugs. Dr. Alia Shatanawi Feb,

Overview Therapeutic Radiopharmaceuticals in Nuclear Medicine Definition: Characteristics of the Ideal Therapeutic Radiopharmaceutical

Slide notes: This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications,

Arteriogram An X-ray of an artery after the injection of dye.

Nuclear medicine in endocrinology

Molecular Breast Imaging: History and Recent Developments

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

Patient Guide to Radioiodine Treatment For Thyrotoxicosis (Overactive Thyroid Gland or Hyperthyroidism)

International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer

Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma.

Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry

Development of a portable gamma imaging system for absorbed radia4on dose control in targeted radionuclide therapy

CEREBRAL BLOOD FLOW AND METABOLISM

TABLE 1 Principal Radiation Emission Data Radiation Mean % per Disintegration Mean Energy (kev) Gamma

Atoms for Health. Atoms for Health The. Atoms for Health - Division of Nuclear Health - Dept of Nuclear Aplications P Andreo DIR-NAHU 1

INDICATIONS AND USAGE

Children's (Pediatric) Nuclear Medicine

Ultra-TechneKow DTE. Click Here to Continue. Click Here to Return to Table of Contents

Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer

The influence of circadian rhythm and biological sex on the biodistribution of iodine-131 in mice

UW MEDICINE PATIENT EDUCATION. Treating Hyperthyroidism with Radioactive Iodine. How to prepare DRAFT. What is radioactive iodine treatment?

DRAXIMAGE MDP-25 Kit for the Preparation of Technetium Tc 99m Medronate Injection. For Intravenous Use DIAGNOSTIC FOR SKELETAL IMAGING

A User-Friendly Thyroid Monitor

Positron Emission Tomography Computed Tomography (PET/CT)

Transcription:

Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide) Overview Indications The Thyroid Uptake Measurement measures the metabolic activity of the thyroid gland as reflected by its extraction of iodine from the blood. Diagnosis of Grave s disease. Evaluation of subacute and chronic thyroiditis. Abnormal thyroid lab work Examination Time Initially: 15 minutes for radiopharmaceutical administration. Delayed measurement at 4 and 24 hours: 15 minutes. Patient Preparation Must be off thyroid hormones: 1. Thyroxine (T-4) for 4 6 weeks 2. Triiodothyronine (T-3) for 2 weeks Must not be taking antithyroid medications: 1. Propylthiouracil (PTU) and Tapazole for at least 7 days. Must not have had intravenous or intrathecal iodinated contrast material (CT with intravenous contrast, IVP, myelogram, angiogram) for at least 4 weeks. Other agents may interfere, but usually only to a small extent. NPO for at least 1 hour after ingesting the radiopharmaceutical. TSH and T4 panel results.

Equipment & Energy Windows Detector: Uptake probe (single crystal probe with flat field collimator). A gamma camera may be substituted for a dedicated uptake probe. Energy window: I-123: 20% window centered at 159 kev. I-131: 20% window centered at 364 kev. Neck phantom. Radiopharmaceutical, Dose, & Technique of Administration Radiopharmaceutical: If performed as part of an I-123 imaging study: The same radiopharmaceutical is used for both studies If not part of an I-123 imaging study: I-123 or I -131. Dose: Imaging plus uptake studies: I-123: 190-270 µci (7-10 MBq). Pedi dose by NACG chart. Alternate uptake study only: I-131: 10 µci (0.37 MBq). Pedi dose by NACG chart. Technique of administration: Oral. Patient Position & Imaging Field Patient position: Sitting. Detector field of view: Neck and Thigh (for patient background counts) Acquisition Protocol Place radiopharmaceutical capsule(s) in neck phantom and position probe perpendicular to phantom with the positioning bar centered on capsule(s) at a standard distance, usually 24 cm. Acquire counts for 1 minute for I-123 and for 2 minutes for I-131; record the counts, time of acquisition, and time of day on the Thyroid Uptake Worksheet. Immediately administer the capsule(s) to the patient. At 4 and 24 hours, position the probe in front of the patient s neck with the positioning bar perpendicular to the neck and with the bar centered half way between the thyroid cartilage and the suprasternal notch. Revised: 3/8/2017 Thyroid Uptake Measurement

Acquire counts for 1 minute for I-123 and for 2 minutes for I-131; record the counts, time of acquisition, and time of day on the Worksheet. Position the probe over the thigh for background measurement. The positioning bar should be perpendicular to the thigh with the bar centered just above the knee. The patient should void before counting over the thigh and the bladder must be clearly outside of the field of view. Acquire counts for 1 minute for I-123 and for 2 minutes for I-131; record the counts, time of acquisition, and time of day on the Worksheet. Protocol Summary Diagram I-123 sodium iodide Action Uptake measurement Uptake measurement Time 0 4 hr. 24 hr. Data Processing Using the Thyroid Uptake Worksheet, calculate the 4 and 24 hour thyroid uptakes. Remember to correct the standard counts for decay. Optional Maneuvers Uptake measurement with a gamma camera: A gamma camera with a pinhole or parallel collimator may be substituted for an uptake probe. Method for timely correction of Data Analysis and reporting errors and notification of referring parties Data Analysis and reporting errors are reported to the interpreting physician and appropriate clinic manager for timely correction and notification of the referring physician via report addendum or STAT call if error is significant.

Principle Radiation Emission Data - I-123 Physical half-life = 13.2 hours. Radiation Mean % per disintegration Mean energy (kev) Gamma-2 83.3 159.0 ce-k, gamma-2 13.6 127.2 Dosimetry - I-123 as Sodium Iodide Organ rads/500 µci mgy/18.5 MBq Thyroid 3.75 37.5 Stomach wall 0.12 1.2 Ovaries 0.02 0.2 Red marrow 0.02 0.2 Liver 0.01 0.1 Whole body 0.01 0.1 Testes 0.01 0.1 Principle Radiation Emission Data - I-131 Physical half-life = 8.04 days. Radiation Mean % per disintegration Mean energy (kev) Beta-4 89.4 191.5 Gamma-14 81.2 364.5 Dosimetry - I-131 as Sodium Iodide Organ rads/10 µci mgy/0.37 MBq Thyroid 13.00 130.0 Stomach wall 0.01 0.1 Total body 0.01 0.1 Ovaries 0.01 0.1 Testes 0.01 0.1 Revised: 3/8/2017 Thyroid Uptake Measurement

THYROID UPTAKE WORKSHEET Nuclear Medicine Department Institution Name ID Age Sex Referring physician Date Zero Hour (time ) Dose in phantom (standard) Background - Net (standard) 4 Hour Uptake (time ) Neck Thigh (background) - Net Standard at zero time Decay correction factor x 0.811 Corrected standard 4 hour uptake = (net neck cpm / corrected standard cpm) x 100% = % 24 Hour Uptake (time ) Neck Thigh (background) - Net Standard at zero time Decay correction factor x 0.284 Corrected standard 24 hour uptake = (net neck cpm / corrected standard cpm) x 100% = % Normal Range: 4 hours = 5-20%; 24 hours = 15-35% Technologist